Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2022

View Archived Issues

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Machine learning approach speeds resistance identification

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Celgene presents new cereblon-binding PROTACs

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Viral replication inhibitors patented by Gilead

New 3,5-diaryl-substituted pyrazoles inhibit prostate cancer cell growth

Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease

AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer

Intranasal influenza-based boost vaccination for preventing SARS-CoV-2 infection

Vir expands partnership with Gates Foundation in HIV and malaria

Preclinical data confirm anticancer activity of two lead compounds in Captor's CT-01 program in HCC

Novel genes identified with risk of obsessive-compulsive disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...